期刊文献+

细胞外信号调节激酶1/2在压力负荷诱导小鼠肥厚心肌和心衰中的表达变化及作用 被引量:2

Effects of ERK1/2 on pressure overload-induced cardiomyopathy and heart failure in mice
下载PDF
导出
摘要 目的:观察细胞外信号调节激酶1/2(ERK1/2)在小鼠主动脉弓缩窄压力超负荷诱导的肥厚心肌组织中不同时点的表达变化,探讨肥厚心肌从代偿到失代偿心力衰竭发生中的分子机制。方法:12周龄C57/BL小鼠通过主动脉弓缩窄(TAC)建立心肌肥厚模型,在1、4、8、12、16周时进行高频心脏超声、血流动力学、组织重量及心肌病理学检测,RT-PCR半定量测定心房利钠肽(ANP)、α-肌球蛋白重链(α-MHC)、bcl-2、bax mRNA,Western blotting方法检测磷酸化ERK1/2蛋白表达的变化。同时建立假手术模型,在不同时点给予相同检测后处死。结果:(1)与假手术组比较,缩窄组左室收缩期、舒张期前壁、后壁厚度、左心室收缩末期、舒张末期内径于术后呈逐渐增加趋势;左心室射血分数于术后12周显著降低(P<0.05)。左室收缩压及左室压力上升和下降最大速率于术后4周明显增加,8-12周保持稳定,16周明显下降;左室舒张末压于术后8周持续增加(均P<0.05)。显示心肌由左室肥厚最终发展为心力衰竭。(2)组织形态学天狼猩红染色测量心肌胶原含量及TUNEL染色测定凋亡指数显示从4周到16周呈增加趋势。(3)与假手术组比较,缩窄组心肌组织ANP术后1周至16周表达呈持续性增加;而α-MHC、bcl-2 mRNA表达呈持续性降低;bcl-2/bax比值下降;缩窄组心肌组织磷酸化ERK1/2蛋白水平术后1周明显增加,4周时达高峰,12周至16周下降至稳定(均P<0.05),总ERK1/2蛋白水平无明显变化。结论:主动脉弓缩窄诱导的压力超负荷可导致左室心肌早期代偿性向心性肥厚向晚期心力衰竭发展。ERK1/2信号转导途径参与压力负荷诱导心肌肥厚和心衰的发生发展过程,并可能通过调控心肌细胞凋亡实现保护作用。 AIM: To explore the changes in extracellular regulated protein kinase (ERK1/2) in the hyper- trophic myocardium induced by pressure overload at the different time courses and to determine the molecular mechanism in the myocardium from hypertrophy to heart failure. METHODS: C57/BL mice, aged 12 week old, were subjected to sham - operation (SH) or transversing aortic constriction (TAC) to establish left ventricular hypertrophy. Echocardiographic assessments, hemodynamic determination, organ weight measurement, morphological and histological examination were performed at 1,4, 8, 12 and 16 weeks after surgery. Meanwhile mRNA levels of atrial natriuretic peptide (ANP) , α - myosin heavy chain (α-MHC), bcl- 2 and bax were measured by RT- PCR, and ERK1/2 levels were detected by Western blotting. The animals in SH group were performed the same tests then sacrificed at 16 weeks. RESULTS: (1) Compared to SH group, LVESd, LVEDd, Awsth, Awdth, Pwsth and Pwdth progressively increased after TAC. Meanwhile, ejection fraction (EF%) significantly decreased at 16th week (P 〈 0. 05 ). LVSP, dp/dtmax and dp/dtmin in TAC group were pro- gressively increased after 4 weeks. From 8 - 12 weeks these parameters maintained stable and then sharply decreased at 16th week (all P 〈 0. 05). However, LVEDP was statistically increased at 8th week. These echocardiographic and hemodynamic changes indicated a development of LVH and eventually progressing towards to heart failure. (2) Histologically, cardiac collagen measured by percentage of Sirius red positive stained area and apoptosis index showed progressive increases from 4 to 16 weeks. (3) Compared to SH group, mRNA levels of ANP was time - dependently increased while α- MHC and Bcl - 2 were time - dependently decreased. The ratio of Bcl - 2/Bax was decreased. Phosphorylation of ERK1/2 was increased at 4th week, then decreased with age of TAC ( all P 〈 0. 05 ). CONCLUSION: Pressure - overload induced by TAC results in a development of LVH from early concentric hypertrophy to late eccentric hypertrophy, and eventually toward cardiac dysfunction or heart failure. Those changes are associated with increase in cell size and cardiac fibrosis. ERK1/2 signaling pathway may involve in the regulation of myocardial cell apoptosis in hypertrophic and failure heart.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2010年第2期209-215,共7页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.30760263) 新疆维吾尔自治区重大专项基金资助项目(No.200733146)
关键词 细胞外信号调节激酶类 主动脉弓缩窄 压力负荷 左室肥大 Extracellular signal -regulated kinases Aortic arch coarctation Pressure overload Left ventricular hypertrophy
  • 相关文献

参考文献3

二级参考文献105

  • 1胡琴,张运,张宪军,冯进波,刘春喜,姜虹,蒋桂花,王蓉.PPARγ在不同周龄apoE-/-小鼠主动脉斑块表达及与斑块成份的相互关系[J].中国病理生理杂志,2006,22(12):2289-2295. 被引量:4
  • 2Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogenactivated protein kinase cascade for the treatment of cancer. Oncogene 2007; 26:3291-3310.
  • 3Lee JC, Kumar S, Griswold DE, Underwood DC, Votta B J, Adams JL. Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology 2000; 47:185-201.
  • 4Hirosumi J, Tuncman'G, Chang L, et al. A central role for JNK in obesity and insulin resistance. Nature 2002; 420:333-336.
  • 5Lewis TS, Shapiro PS, Ahn NG. Signal transduction through MAP kinase cascades. Adv Cancer Res 1998; 74:49-139.
  • 6Raman M, Chen W, Cobb MH. Differential regulation of MAPKs. Oncogene 2007; 26:3100-3112.
  • 7Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001 ; 81:807-869.
  • 8Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002; 298:1911-1912.
  • 9Yoon S, Seger R. The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions. Growth Factors 2006; 24:21-44.
  • 10Gille H, Kortenjann M, Thomae O, et al. ERK phosphorylation potentiates Elk- 1-mediated ternary complex formation and transactivation. EMBO J 1995; 14:951-962.

共引文献84

同被引文献38

  • 1常巨平,祝胜郎,余学清,李就鸿,张军,陈路,陈结慧.ERK1/2信号蛋白在糖尿病小鼠肾组织中的表达[J].中国病理生理杂志,2007,23(9):1804-1807. 被引量:14
  • 2LIANG K V,WILLIAMS A W,GREENE E L,et al.Acute decompensated heart failure and the cardiorenal syndrome[J].Crit Care Med,2008,36(suppl):S75-S88.
  • 3JIN H,AXTELL M J,DAHLBECK D,et al.NPK1 and MEKKI-like mitogen-activated protein kinase,regulates innate immunity and development in plants[J].Devel,2002,3(2):291-297.
  • 4HAYASHI M,LEE J D.Role of the BMK1/ERK5 signaling pathway:lessons from knockout mice[J].J Mol Med,2004,82(12):800-808.
  • 5FRANCIS G S.Pathophysiology of chronic heart failure[J].Am J Med,2001,10(7):37-46.
  • 6TAKAHASHI H,ICHIHARA A,KANESHIRO Y,et al.Regression of nephropathy developed in diabetes by (pro)rennin receptor blockade[J].Am Soc Nephrol,2007,18(7):2054-2061.
  • 7ABDELLATIF A A.The role of renin inhibition in treating the hypertensive patient with diabetes:a summary of preclinical and clinical evidence[J].Expert Rev Cardiovasc Ther,2012,10(2):251-263.
  • 8NGUYEN G,DELARUE F,BURCKLE C,et al.Pivotal role of the rennin/prorenin receptor in angiotensin Ⅱ production and cellular responses to rennin[J].Clin Invest,2002,109(11):1417-1427.
  • 9BURCKLE C,BADER M.Prorenin and its ancient receptor[J].Hypertension,2006,48(4):549-551.
  • 10SATOFUKA S,ICHIHARA A,NAGAI N,et al.(Pro)renin receptor-mediaten signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation[J].Diabetes,2009,58(7):1625-1633.

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部